Cite
HARVARD Citation
Lissitchkov, T. et al. (2019). Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program. Therapeutic advances in hematology. p. . [Online].